$7 - $30 per DALY averted: Too good to be true or (missed) opportunity?

Join GOAL 3 and Rethink Priorities as we explore whether continous patient monitoring (IMPALA) could be one of the most neglected cost-effective interventions in global health.

Cost-effectiveness Webinar
Nov 4: 16:00 - 17:00 CET (10am EST)
Register Here

Program

  • Problem statement and theory of change of IMPALA.
  • Overview of current evidence for IMPALA.
  • Explanation of recent RP report methodology and results.
  • How does IMPALA compare to other
    cost-effective global health interventions?
  • Discussing next steps.

What is the webinar about?

A study on the cost-effectivness of IMPALA (a continous patient monitoring system and digital health platform from GOAL 3) was recently published in in the BMJ Paeds Open. Using this study and the full body of evidence from GOAL 3, Rethink Priorities - an independent research organization - conducted an analysis of IMPALA's cost-effectiveness. After heavy discounts they calculated that IMPALA costs $7–17 and $12–30 per DALY averted for paediatrics and neonates respectively. Importantly, the report from Rethink Priorities concludes that IMPALA is cost-effective not just because of the mortality reduction, but because of how affordable the intervention is.

‍In this webinar GOAL 3 and Rethink Priorities will dive into the evidence of IMPALA, and explore what this report means for those looking to implement or support cost-effective global health interventions. If you would like to read the report you can find it here.

Speakers

Britta Jewell

Britta Jewell is a Senior Researcher at Rethink Priorities. Her background is in applying mathematical modeling of global health interventions to improve impact and cost-effectiveness in sub-Saharan Africa. Britta holds a PhD in Infectious Disease Epidemiology from Imperial College London and an MSc in the History of Science, Medicine, and Technology from the University of Oxford.

Niek Versteegde

Dr Niek Versteegde is a general practitioner, tropical doctor, and founder of GOAL 3. He is also a board member of the Friends of Sengerema Foundation, which supports a rural mission hospital in Tanzania. It was his time in Tanzania that sparked the idea for IMPALA after seeing the tremondous need for improved technology to manage and prioritize patients.

Frequently asked questions

Who should attend this Webinar?

This webinar is relevant for people who are interested in: effective giving and measurable impact; global health and hospital care in Africa; maternal, newborn and child health; health technology in low-resource settings; cost-effectiveness and evidence generation. You do not need medical or technical knowledge to join.

Will there be a time for asking questions at the Webinar?

Yes, we love to engage with people interested in this subject, and will leave plenty of times for questions during the webinar. If you register, but cannot attend, you will receive a recording following the webinar.